It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. Timeline of Otsuka's History 2004~2013

About OtsukaTimeline of Otsuka's History
2004~2013

  • CorpCorporate
  • PhPharmaceutical business
  • NCNutraceutical business

2004

Corp

Tokushima Vortis, a professional soccer team, launched

With the aim of revitalizing the region, Tokushima Vortis was established with the support of local residents, government bodies, and companies. Otsuka Pharmaceutical and other Otsuka Group companies sponsor the team.

2005

NC

InnerSignal launched

Full-scale entry into the Cosmedics* business.

  • Cosmedics: cosmetics + medicine

Kenja-no-shokutaku (Wise Man's Dining, currently sold as Kenja-no-shokutaku Double Support) launched

Xuzhou VV Food & Beverage (now VV Food & Beverage Co., Ltd.) joined group

2006

Ph

ABILIFY launched in Japan

Antipsychotic drug

NC

SOYJOY launched in Japan

First product from the Soylution* concept

  • Soylution = Soy + solution

2007

Corp

Otsuka Group's corporate symbol created

Ph

Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) established in U.S.

OPDC oversees the clinical development strategy and planning, as well as marketing planning, of Otsuka's pharmaceutical business in many Western countries.

2008

Corp

Taro Iwamoto appointed president of Otsuka Pharmaceutical Co., Ltd.

Otsuka Holdings Co., Ltd. established

Ph

Alliance with Belgium-based UCB

Otsuka Pharmaceutical and UCB entered an agreement for co-development and co-promotion of pharmaceuticals in Japan including the anti-epileptic drug Keppra.

Acquisition of worldwide rights to Busulfex

Busulfex is the only conditioning agent approved by the US FDA for use prior to allogeneic hematopoietic progenitor cell transplantation.

NC

France-based ALMA stake acquired

A major mineral water company in Europe

UL・OS launched

Otsuka's second cosmedics brand (following the launch of InnerSignal three years earlier)

2009

Ph

Samsca launched in the U.S

Oral vasopressin V2-receptor antagonist

NC

France-based Nutrition et Santé joined group

Leading company in the functional and nutritional food markets of Europe

2010

Corp

Otsuka Holdings listed on the First Section of Tokyo Stock Exchange

NC

SOYSH launched

Carbonated soy beverage

Gerblé introduced to Japan from Nutrition et Santé in France

2011

Corp

BeanStalk Kids Center TOKUSHIMA opened

Opened as Otsuka Pharmaceutical's first in-house child care center in Tokushima

Heartful Kawauchi Co., Ltd. established as a special subsidiary of Otsuka Pharmaceutical

Heartful Kawauchi Co., Ltd. was established in Japan with the purpose to provide opportunities for people with physical and/or mental disabilities. It seeks to provide them with meaningful work in order to live equally with the rest of society and to work free from discrimination.

Ph

Global alliance with H. Lundbeck A/S in Central Nervous System (CNS) diseases

Otsuka S.A. established in Switzerland

2012

Ph

Agreement signed with US-based Proteus Digital Health, Inc.

Otsuka entered into an agreement to develop new pharmaceuticals that use sensor technology.

Mucosta ophthalmic suspension launched

Treatment for dry eye

NC

Otsuka Thang Nutrition established in Vietnam

SoyCarat launched

2013

Ph

Abilify Maintena launched in the U.S.

Antipsychotic drug

Neupro patch introduced

Dopaminergic antiparkinsonian drug
Drug for restless legs syndrome

Astex Pharmaceuticals joined group

Otsuka Europe Development and Commercialisation Ltd. established in the U.K.

NC

POCARI SWEAT ION WATER launched

OMUGI SEIKATSU (Barley Life) launched